Latest News

New Oxford Knee Score – Activity and Participation Questionnaire (OKS-APQ) available from Isis Outcomes

3rd July 2015

All News | Clinical Outcomes | Uncategorized

The Oxford Knee Score - Activity and Participation Questionnaire (OKS-APQ) is a Patient Reported Outcome Measure designed and validated to supplement the Oxford Knee score as an additional scale.

Updated MOxFQ User Manual now available

26th May 2015

All News | Clinical Outcomes

Updated user manual available for the Manchester Oxford Foot and Ankle Questionnaire (MOxFQ) now available from Isis Outcomes

Isis Outcomes at ISPOR 20th Annual International Meeting

15th May 2015

All News | Clinical Outcomes

Isis Outcomes will be represented at the ISPOR 20th Annual International Meeting to be held in Philadelphia, from May 16th – 20th, 2015. In the conference Isis Outcomes will be presenting an electronic version of the Parkinson’s Disease Questionnaire (PDQ-39).

ISPOR 17th Annual European Congress

27th October 2014

All News | Clinical Outcomes

Isis Outcomes will be presenting on two recent collaborative ePRO activities at this event in Amsterdam 8th – 12th November 2014. In association with Professor Crispin Jenkinson and colleagues at the University of Oxford, PharmaQuest Ltd and CRF Health, Isis Outcomes will explain where it has supported the development of ePRO versions of its portfolio of health outcomes instruments.

Isis Outcomes and Oxford Health Outcomes experts present at eCOA 2014

24th June 2014

All News | Clinical Outcomes

The eCOA Forum brings together world leaders in PRO development and health outcomes.

New Mild Cognitive Impairment Questionnaire Available from Isis Outcomes

17th January 2014

All News | Clinical Outcomes

A new health outcomes questionnaire for the measurement of health-related quality of life.

101 Companies in 25 Years for Oxford’s Oxford University Innovation

4th October 2013

All News | Clinical Outcomes | Spinouts & Startups | Technology News

As the technology commercialisation company of Oxford University, Oxford University Innovation, celebrates its 25th anniversary, it also looks back on 101 companies that originate from Isis. Oxford Biotrans, the 101st company, will commercialise new routes to high-value chemicals using patented enzyme technology.

Oxford’s Electronic Endometriosis Survey brings Women’s Health into Focus

4th April 2013

All News | Clinical Outcomes | Technology News

Oxford University Innovation, the University of Oxford’s technology transfer company, in partnership with ERT and PharmaQuest have developed an electronic questionnaire to better understand a condition that affects 10% of women. Endometriosis is a chronic, painful gynaecological condition that typically affects women of reproductive age and can lead to infertility. The questionnaire gauges the success of current endometriosis treatments as well as the impact on patient quality-of-life.

New Language Versions of the Endometriosis Health Profile (EHP) Added to Isis Outcomes PRO Library

10th May 2011

All News | Clinical Outcomes | Technology News

Sixteen new language versions have been completed by Oxford Outcomes Ltd, a research agency specialising in the translation and linguistic validation of patient reported outcome (PRO) measures.

New Products from Isis Outcomes at ISPOR 2011

18th April 2011

All News | Clinical Outcomes | Technology News

Isis Outcomes will be exhibiting at the ISPOR 16th Annual International Meeting to be held in Baltimore, from May 21st - 25th 2011. The Health Outcomes business at Oxford University Innovation, Isis Outcomes, offers a growing selection of Patient-Reported Outcome measures (PROs) to global healthcare clients, for conditions such as Parkinson’s, Endometriosis, Orthopaedics and Motor Neurone Disease/Amyotrophic Lateral Sclerosis (ALS).

News

Ready to get in touch?